Jin Medical International Ltd. (ZJYL)
NASDAQ: ZJYL · Real-Time Price · USD
0.6499
+0.0134 (2.11%)
At close: Aug 13, 2025, 4:00 PM
0.6850
+0.0351 (5.40%)
Pre-market: Aug 14, 2025, 8:58 AM EDT

Jin Medical International Revenue

In the fiscal year ending September 30, 2024, Jin Medical International had annual revenue of $23.50M with 18.57% growth. Jin Medical International had revenue of $12.95M in the half year ending September 30, 2024, with 33.14% growth.

Revenue (ttm)
$23.50M
Revenue Growth
+18.57%
P/S Ratio
4.33
Revenue / Employee
$87,368
Employees
269
Market Cap
101.74M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202423.50M3.68M18.57%
Sep 30, 202319.82M630.92K3.29%
Sep 30, 202219.19M-1.57M-7.58%
Sep 30, 202120.76M4.57M28.22%
Sep 30, 202016.19M-4.17M-20.49%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 422.82B
Johnson & Johnson 90.63B
Merck & Co. 63.62B
AbbVie 58.33B
AstraZeneca 56.50B
Novartis AG 55.19B
Eli Lilly and Company 53.26B
Novo Nordisk 49.11B
Revenue Rankings